| Literature DB >> 32144385 |
So Young Kim1, Dong Jun Oh2, Bumjung Park3, Hyo Geun Choi4.
Abstract
The aim of this study was to investigate the association of body mass index (BMI), alcohol consumption, and smoking status with the occurrence of Bell's palsy. The Korean National Health Insurance Service-Health Screening Cohort of a ≥ 40-year-old population from 2000-2003 was used. A total of 5,632 Bell's palsy participants were matched with 22,528 control participants in terms of age, sex, income, region of residence, and past medical histories of hypertension, diabetes, and dyslipidemia. Bell's palsy was classified by a history of ≥2 diagnoses with ICD-10 code (G510) and steroid treatment. BMI (kg/m2) was classified as <18.5 (underweight), ≥18.5 to <23 (normal), ≥23 to <25 (overweight), ≥25 to <30 (obese I), and ≥30 (obese II). Alcohol consumption was divided into non-drinkers and those who drank 2-3 times a month, 1-2 times a week, and ≥3 times a week. Smoking status was categorized as current smokers, past smokers, and non-smokers. The odds of obesity, alcohol consumption, and smoking with Bell's palsy were analyzed using logistic regression analysis. BMI showed proportionally positive associations with Bell's palsy (adjusted OR [95% CI] = 0.61 [0.47-0.79] for underweight, 1.16 [1.08-1.26] for normal, 1.24 [1.15-1.33] for obese I, and 1.61 [1.38-1.88] for obese II, P < 0.001). The odds of alcohol consumption with Bell's palsy were 0.90 (95% confidence interval [CI] = 0.82-0.99) for 2-3 times a month, 0.77 (95% CI = 0.69-0.85) for 1-2 times a week, and 0.79 (95% CI = 0.71-0.88) for ≥3 times a week compared to nondrinkers (P < 0.001). Smoking did not show a relationship with the occurrence of Bell's palsy. Obesity was related to the risk of Bell's palsy in the population over 40 years old. On the other hand, alcohol consumption was negatively associated with the occurrence of Bell's palsy.Entities:
Mesh:
Year: 2020 PMID: 32144385 PMCID: PMC7060281 DOI: 10.1038/s41598-020-61240-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
General characteristics of the participants.
| Characteristics | Total participants | ||
|---|---|---|---|
| Bell’s palsy (n, %) | Control (n, %) | P-value | |
| Age (years old) | 1.000 | ||
| 40–44 | 132 (2.3) | 528 (2.3) | |
| 45–49 | 644 (11.4) | 2,576 (11.4) | |
| 50–54 | 1,041 (18.5) | 4,164 (18.5) | |
| 55–59 | 989 (17.6) | 3,956 (17.6) | |
| 60–64 | 899 (16.0) | 3,596 (16.0) | |
| 65–69 | 820 (14.6) | 3,280 (14.6) | |
| 70–74 | 607 (10.8) | 2,428 (10.8) | |
| 75–79 | 339 (6.0) | 1,356 (6.0) | |
| 80–84 | 137 (2.4) | 548 (2.4) | |
| 85+ | 24 (0.4) | 96 (0.4) | |
| Sex | 1.000 | ||
| Male | 2,807 (49.8) | 11,228 (49.8) | |
| Female | 2,825 (50.2) | 11,300 (50.2) | |
| Income | 1.000 | ||
| 1 (lowest) | 860 (15.3) | 3,440 (15.3) | |
| 2 | 696 (12.4) | 2,784 (12.4) | |
| 3 | 858 (15.2) | 3,432 (15.2) | |
| 4 | 1,291 (22.9) | 5,164 (22.9) | |
| 5 (highest) | 1,927 (34.2) | 7,708 (34.2) | |
| Region of residence | 1.000 | ||
| Urban | 2,441 (43.3) | 9,764 (43.3) | |
| Rural | 3,191 (56.7) | 12,764 (56.7) | |
| Hypertension | 1.000 | ||
| Yes | 2,172 (38.6) | 8,688 (38.6) | |
| No | 3,460 (61.4) | 13,840 (61.4) | |
| Diabetes | 1.000 | ||
| Yes | 1,105 (19.6) | 4,420 (19.6) | |
| No | 4,527 (80.4) | 18,108 (80.4) | |
| Dyslipidemia | 1.000 | ||
| Yes | 748 (13.3) | 2,992 (13.3) | |
| No | 4,884 (86.7) | 19,536 (86.7) | |
| BMI (kg/m2) | <0.001* | ||
| Underweight | 70 (1.2) | 506 (2.2) | |
| Normal | 1,677 (29.8) | 7,527 (33.4) | |
| Overweight | 1,574 (27.9) | 6,142 (27.3) | |
| Obese I | 2,047 (36.3) | 7,592 (33.7) | |
| Obese II | 264 (4.7) | 761 (3.4) | |
| Smoking | 0.862 | ||
| Nonsmoker | 4,078 (72.4) | 16,253 (72.1) | |
| Past smoker | 635 (11.3) | 2,531 (11.2) | |
| Current smoker | 919 (16.3) | 3,744 (16.6) | |
| Drinking alcohol | <0.001* | ||
| Nondrinker | 3,747 (66.5) | 14,292 (63.4) | |
| 2–3 times a month | 719 (12.8) | 2,910 (12.9) | |
| 1–2 times a week | 616 (10.9) | 2,848 (12.6) | |
| ≥3 times a week | 550 (9.8) | 2,478 (11.0) | |
BMI: body mass index, kg/m2.
Underweight: <18.5, normal: ≥18.5 to <23, overweight: ≥23 to <25, obese I: ≥ 25 to <30, obese II: ≥ 30.
*Chi-square test; significant at P < 0.05.
Crude and adjusted odds ratios (95% confidence interval) of smoking, drinking alcohol, and obesity for Bell’s palsy.
| Characteristics | Crude model | Adjusted model | ||
|---|---|---|---|---|
| Crude† | P-value | Adjusted†,‡ | P-value | |
| Smoking | 0.830 | 0.594 | ||
| Current smoker | 0.97 (0.89–1.07) | 0.545 | 1.05 (0.95–1.15) | 0.321 |
| Past smoker | 0.99 (0.90–1.10) | 0.912 | 1.03 (0.93–1.15) | 0.573 |
| Nonsmoker | 1.00 | 1.00 | ||
| Alcohol | <0.001* | <0.001* | ||
| ≥3 times a week | 0.80 (0.72–0.89) | <0.001* | 0.79 (0.71–0.88) | <0.001* |
| 1–2 times a week | 0.78 (0.71–0.86) | <0.001* | 0.77 (0.69–0.85) | <0.001* |
| 2–3 times a month | 0.91 (0.82–1.00) | 0.039* | 0.90 (0.82–0.99) | 0.025* |
| Nondrinker | 1.00 | 1.00 | ||
| BMI (kg/m2) | <0.001* | <0.001* | ||
| Underweight | 0.61 (0.47–0.79) | <0.001* | 0.61 (0.47–0.79) | <0.001* |
| Normal | 1.00 | 1.00 | ||
| Overweight | 1.16 (1.08–1.26) | <0.001* | 1.16 (1.08–1.26) | <0.001* |
| Obese I | 1.23 (1.15–1.33) | <0.001* | 1.24 (1.15–1.33) | <0.001* |
| Obese II | 1.60 (1.38–1.87) | <0.001* | 1.61 (1.38–1.88) | <0.001* |
BMI: body mass index, kg/m2.
Underweight: <18.5, normal: ≥18.5 to <23, overweight: ≥23 to <25, obese I: ≥ 25 to <30, obese II: ≥ 30.
*Conditional logistic regression analysis; significant at P < 0.05.
†Models stratified by age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia.
‡Adjusted model of obesity, smoking state (current smokers and past smokers compared to nonsmokers), and frequency of drinking alcohol (≥3 times a week, 1–2 times a week, and 2–3 times a month compared to nondrinkers).
Crude and adjusted odds ratios (95% confidence interval) of smoking, drinking alcohol, and obesity for Bell’s palsy in each stratified group according age and sex.
| Characteristics | Crude model | Adjusted model | ||
|---|---|---|---|---|
| Crude | P-value | Adjusted† | P-value | |
| Smoking | 0.460 | 0.608 | ||
| Current smoker | 0.95 (0.84–1.07) | 0.393 | 1.02 (0.89–1.15) | 0.811 |
| Past smoker | 1.04 (0.90–1.20) | 0.590 | 1.08 (0.93–1.25) | 0.325 |
| Nonsmoker | 1.00 | 1.00 | ||
| Alcohol | 0.002* | 0.001* | ||
| ≥3 times a week | 0.84 (0.72–0.97) | 0.020* | 0.82 (0.71–0.96) | 0.012* |
| 1–2 times a week | 0.79 (0.69–0.90) | <0.001* | 0.78 (0.68–0.89) | <0.001* |
| 2–3 times a month | 0.95 (0.84–1.07) | 0.378 | 0.94 (0.83–1.06) | 0.298 |
| Nondrinker | 1.00 | 1.00 | ||
| BMI (kg/m2) | <0.001* | <0.001* | ||
| Underweight | 0.67 (0.44–1.01) | 0.055 | 0.67 (0.44–1.01) | 0.056 |
| Normal | 1.00 | 1.00 | ||
| Overweight | 1.24 (1.11–1.38) | <0.001* | 1.24 (1.11–1.38) | <0.001* |
| Obese I | 1.23 (1.11–1.37) | <0.001* | 1.24 (1.11–1.37) | <0.001* |
| Obese II | 1.65 (1.33–2.04) | <0.001* | 1.66 (1.33–2.05) | <0.001* |
| Smoking | 0.707 | 0.352 | ||
| Current smoker | 1.01 (0.88–1.16) | 0.862 | 1.10 (0.95–1.27) | 0.197 |
| Past smoker | 0.95 (0.81–1.10) | 0.463 | 0.98 (0.84–1.14) | 0.804 |
| Nonsmoker | 1.00 | 1.00 | ||
| Alcohol | <0.001* | <0.001* | ||
| ≥3 times a week | 0.77 (0.66–0.89) | 0.001* | 0.76 (0.65–0.89) | 0.001* |
| 1–2 times a week | 0.78 (0.66–0.92) | 0.003* | 0.76 (0.64–0.90) | 0.002* |
| 2–3 times a month | 0.85 (0.73–0.99) | 0.032* | 0.84 (0.72–0.98) | 0.025* |
| Nondrinker | 1.00 | 1.00 | ||
| BMI (kg/m2) | <0.001* | <0.001* | ||
| Underweight | 0.58 (0.42–0.80) | 0.001* | 0.57 (0.41–0.79) | 0.001* |
| Normal | 1.00 | 1.00 | ||
| Overweight | 1.09 (0.97–1.21) | 0.136 | 1.09 (0.98–1.22) | 0.128 |
| Obese I | 1.24 (1.11–1.37) | <0.001* | 1.24 (1.12–1.38) | <0.001* |
| Obese II | 1.56 (1.26–1.93) | <0.001* | 1.56 (1.26–1.94) | <0.001* |
| Smoking | 0.816 | 0.544 | ||
| Current smoker | 0.97 (0.88–1.07) | 0.577 | 1.05 (0.95–1.16) | 0.319 |
| Past smoker | 1.01 (0.90–1.12) | 0.924 | 1.05 (0.94–1.17) | 0.419 |
| Nonsmoker | 1.00 | 1.00 | ||
| Alcohol | <0.001* | <0.001* | ||
| ≥3 times a week | 0.79 (0.71–0.89) | <0.001* | 0.78 (0.69–0.88) | <0.001* |
| 1–2 times a week | 0.77 (0.68–0.86) | <0.001* | 0.75 (0.67–0.85) | <0.001* |
| 2–3 times a month | 0.90 (0.80–1.02) | 0.091 | 0.89 (0.79–1.00) | 0.058 |
| Nondrinker | 1.00 | 1.00 | ||
| BMI (kg/m2) | <0.001* | <0.001* | ||
| Underweight | 0.62 (0.44–0.89) | 0.008* | 0.62 (0.43–0.88) | 0.007* |
| Normal | 1.00 | 1.00 | ||
| Overweight | 1.20 (1.08–1.34) | 0.001* | 1.20 (1.08–1.34) | 0.001* |
| Obese I | 1.23 (1.11–1.37) | <0.001* | 1.23 (1.11–1.37) | <0.001* |
| Obese II | 1.99 (1.57–2.51) | <0.001* | 2.00 (1.58–2.53) | <0.001* |
| Smoking | 0.594 | 0.565 | ||
| Current smoker | 1.00 (0.75–1.33) | 0.984 | 1.07 (0.80–1.44) | 0.629 |
| Past smoker | 0.76 (0.45–1.28) | 0.307 | 0.78 (0.46–1.31) | 0.347 |
| Nonsmoker | 1.00 | 1.00 | ||
| Alcohol | 0.247 | 0.206 | ||
| ≥3 times a week | 0.87 (0.62–1.20) | 0.382 | 0.86 (0.62–1.19) | 0.356 |
| 1–2 times a week | 0.84 (0.66–1.06) | 0.145 | 0.83 (0.65–1.05) | 0.115 |
| 2–3 times a month | 0.90 (0.77–1.06) | 0.197 | 0.90 (0.77–1.05) | 0.186 |
| Nondrinker | 1.00 | 1.00 | ||
| BMI (kg/m2) | <0.001* | <0.001* | ||
| Underweight | 0.60 (0.42–0.88) | 0.008* | 0.60 (0.42–0.87) | 0.007* |
| Normal | 1.00 | 1.00 | ||
| Overweight | 1.13 (1.01–1.25) | 0.034* | 1.13 (1.01–1.26) | 0.033* |
| Obese I | 1.24 (1.12–1.37) | <0.001* | 1.24 (1.12–1.38) | <0.001* |
| Obese II | 1.39 (1.14–1.70) | 0.001* | 1.39 (1.14–1.70) | 0.001* |
BMI: body mass index, kg/m2.
Underweight: <18.5, normal: ≥18.5 to <23, overweight: ≥23 to <25, obese I: ≥25 to <30, obese II: ≥30.
*Conditional logistic regression analysis; significant at P < 0.05.
†Models stratified by age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia.
‡Adjusted model of obesity, smoking state (current smokers and past smokers compared to nonsmokers), and frequency of drinking alcohol (≥3 times a week, 1–2 times a week, and 2–3 times a month compared to nondrinkers).
Figure 1A schematic illustration of the participant selection process used in the present study. Of a total of 514,866 possible participants, 5,632 Bell’s palsy patients were matched with 22,528 control participants for age group, sex, income group, region of residence, and past medical histories.